Keminntek Pharmaceuticals Llp - Company Profile

Q: Who are the current directors of Keminntek Pharmaceuticals Llp?

The current directors of Keminntek Pharmaceuticals Llp are Sreenivas Peddolla, Srinivas Kolupula.

It is a pharma limited liability partnership based in Hyderabad, Telangana, India, established in 2018.

2018 Hyderabad, Telangana, India Active

Last Updated: December 23, 2025

About Keminntek Pharmaceuticals Llp

Keminntek Pharmaceuticals Llp, a active limited liability partnership, was established on 13 November 2018 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAN-5408. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹1.00 M.

Its leadership includes Sreenivas Peddolla (Designated Partner), Srinivas Kolupula (Designated Partner). Its latest date of accounts and solvency statement 31 March 2020. It is based at H. No: 9-94/7 Plot No. 76, Laxmi Nagar Colony Boduppal, Medchal, Hyderabad, Telangana, 500039.

Company Details

CIN/LLPIN
AAN-5408
Incorporation Date
13 November 2018
Total Obligation of Contribution
₹1.00 M
ROC Code
Roc Hyderabad
Company Status
Active

Key Metrics

Obligation of Contribution ₹ 1.00 M as on 23-12-2025
Company Age 7 Year, 3 Months
Last Filing with ROC 31 Mar 2020
Revenue Growth **** % (FY 2020)
Profit Growth **** -37.53% (FY 2020)
Ebitda ****
Total Assets **** 50.93% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Keminntek Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Keminntek Pharmaceuticals Llp?

Current Designated Partners

Name	Designation	Appointment Date	Status
Sreenivas Peddolla	Designated Partner	13 Nov 2018	Current
Srinivas Kolupula	Designated Partner	13 Nov 2018	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Keminntek Pharmaceuticals Llp.

Keminntek Pharmaceuticals Llp, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 37.53% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

50.93%

*******

Profit or Loss

*******

-37.53%

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Keminntek Pharmaceuticals Llp?

Unlock access to Keminntek Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Keminntek Pharmaceuticals Llp?

Unlock and access historical data on people associated with Keminntek Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Keminntek Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keminntek Pharmaceuticals Llp's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Keminntek Pharmaceuticals Llp

Recent Activity within the Organization

Annual General Meeting

Keminntek Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2021 as per latest MCA records. was recorded as a recent event.
31 Mar 2021
Statement of Assets & Liabilities

The activity Keminntek Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was completed.
31 Mar 2020
Director Appointment

Progress on Sreenivas Peddolla was appointed as a Designated Partner was appointed as a Designated Partner on 13 Nov 2018 & has been associated with this company since 7 years 3 months . was documented.
13 Nov 2018
Director Appointment

The activity Srinivas Kolupula was appointed as a Designated Partner was appointed as a Designated Partner on 13 Nov 2018 & has been associated with this company since 7 years 3 months . was completed.
13 Nov 2018
LLP Incorporation

Keminntek Pharmaceuticals Llp was registered on 13 Nov 2018 with Roc Hyderabad & aged 7 years 3 months as per MCA records. was recorded as a recent event.
13 Nov 2018

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the LLPIN of Keminntek Pharmaceuticals Llp?

The LLPIN of Keminntek Pharmaceuticals Llp is AAN-5408.

Where is Keminntek Pharmaceuticals Llp headquartered?

Keminntek Pharmaceuticals Llp is headquartered at H. No: 9-94/7 Plot No. 76, Laxmi Nagar Colony Boduppal, Medchal, Hyderabad, Telangana, 500039.

When was Keminntek Pharmaceuticals Llp incorporated?

Keminntek Pharmaceuticals Llp was incorporated on 13 November 2018.

Who are the current directors of Keminntek Pharmaceuticals Llp?

The current directors of Keminntek Pharmaceuticals Llp are

What is the primary industry of Keminntek Pharmaceuticals Llp?

The primary industry of Keminntek Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available